Eccentric Manual Resistance Training in Patients With Ischemic CMP

Sponsor
Vienna Hospital Association (Other)
Overall Status
Recruiting
CT.gov ID
NCT04829955
Collaborator
(none)
28
1
3
10.1
2.8

Study Details

Study Description

Brief Summary

Patients with ischemic cardiomyopathy and mildly reduced ejection fraction suffer from reduced functional capacity and fatigue caused by loss of muscle strength and reduced aerobic capacity.

A few studies have shown that structured endurance and resistance training programs were able to improve walking capacity and limb strength.

Although both concentric and eccentric training programs are beneficial for these patients, eccentric training is less stressful to the cardiovascular system.

The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will lead to superior results compared to concentric training.

Condition or Disease Intervention/Treatment Phase
  • Other: Eccentric manual resistance training
  • Other: Concentric manual resistance resistance training
N/A

Detailed Description

BACKGROUND: Eccentric resistance training demonstrated positive effects in ischemic cardiomyopathy patients in several studies. These studies were mainly set on device-based training interventions comparing eccentric-orientated and concentric-orientated training. Eccentric-orientated training induced comparable positive effects on cardiac and functional levels and even better effects on muscle strength improvement.

RESEARCH AIMS: The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will allow a more significant improvement in maximum voluntary contraction force of the knee extensors compared to concentric training.

In contrast to previous studies, these interventions will be set without use of training devices.

In addition, changes in the muscle cross section of the quadriceps muscle will be calculated by skeletal muscle ultrasound. Functional changes and quality of life will be assessed using one minute sit to stand test, six minutes walking test and Kansas City Cardiomyopathy Questionnaire. Cardiac outcome parameters will be assessed by using body composition and hemodynamic parameters as well as echocardiography, laboratory values and specific biomarkers for sarcopenia / cachexia.

METHODS: The investigators propose to run a monocentric, prospective, double arm, open, randomized controlled trial. Eccentric-orientated training will be delivered to 30 ischemic cardiomyopathy patients.

These patients will be randomized into two groups at the beginning, followed by a 6-weeks observation phase (without intervention for internal quality control of the measurement parameters). The intervention-phase will consist of six weeks of three times weekly either eccentric or concentric-oriented training.

Outcome measurements will take place after randomization, after 6 weeks of observation as well as after the intervention phase

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Eccentric Manual Resistance Training for Improvement of Strength and Function in Patients With Ischemic Cardiomyopathy and Mildly Reduced Ejection Fraction
Actual Study Start Date :
Jun 29, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Observation phase

After screening and randomization for either the eccentric orientated intervention group or the concentric orientated intervention group, all measurements will be made for the first time by investigators at point A1. An observational phase for six weeks will follow to achieve an intern acceptance sampling for the measurements which will be used.

Active Comparator: Eccentric training group

Subjects in the eccentric training group (GEC) will attend six weeks of eccentric orientated training. The eccentric orientated training will use the cadence 3-0-1 for eccentric - break - concentric. 3 sessions/week 60 minutes per session including a warming up and cool down phase 6 exercises total of 18 sessions

Other: Eccentric manual resistance training
Eccentric bodyweight resistance training

Active Comparator: Concentric training group

The concentric training group (GCO) will attend six weeks of concentric orientated training. Each group will perform a manual resistance/bodyweight resistance training accentuating the concentric phase of the movement. The concentric orientated training will use the cadence 1-0-3 for eccentric - break - concentric. 3 sessions/week 60 minutes per session including a warming up and cool down phase 6 exercises total of 18 sessions

Other: Concentric manual resistance resistance training
Concentric bodyweight resistance training

Outcome Measures

Primary Outcome Measures

  1. MVC of knee-extensors isometric [Baseline]

    Knee dynamometer

  2. MVC of knee-extensors isometric [After 6 weeks of observation]

    Knee dynamometer

  3. MVC of knee-extensors isometric [After 6 weeks of training]

    Knee dynamometer

Secondary Outcome Measures

  1. Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement [Baseline]

    Sonographic measurement

  2. Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement [After 6 weeks of observation]

    Sonographic measurement

  3. Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement [After 6 weeks of training]

    Sonographic measurement

  4. Six- minutes walking test (6MWT) [Baseline]

    Measures the walking distance within 6 minutes.

  5. Six- minutes walking test (6MWT) [After 6 weeks of observation]

    Measures the walking distance within 6 minutes.

  6. Six- minutes walking test (6MWT) [After 6 weeks of training]

    Measures the walking distance within 6 minutes.

  7. One-minute sit to stand test [Baseline]

    Measures sit to stand repetitions within one minute.

  8. One-minute sit to stand test [After 6 weeks of observation]

    Measures sit to stand repetitions within one minute.

  9. One-minute sit to stand test [After 6 weeks of training]

    Measures sit to stand repetitions within one minute.

  10. Quality of life (QoL) [Baseline]

    Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.

  11. Quality of life (QoL) [After 6 weeks of observation]

    Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.

  12. Quality of life (QoL): questionnaire [After 6 weeks of training]

    Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male / female, 45-85a

  • Ischemic cardiomyopathy with mildly reduced ejection fraction (40 -50%)

  • Coronary heart disease

Exclusion Criteria:
  • Acute coronary syndrome, myocarditis or pericarditis in the last 3 months

  • Cardiac decompensation in the last 3 months

  • Severe symptomatic heart failure NYHA IV (New York Heart Association)

  • Device - carrier (ICD= Intracardial Defibrillator, CRT= Cardiac Resynchronization Therapy, PM=Pacemaker)

  • Hemodynamically significant valvular disease

  • Symptomatic cardiac arrhythmia

  • Intractable, uncontrolled hypertension (repetitive blood pressure > 150/100)

  • Severe comorbidities, which lead to study exclusion by the investigator

  • Pregnancy / nursing

Contacts and Locations

Locations

Site City State Country Postal Code
1 Klinik Ottakring Vienna Austria 1160

Sponsors and Collaborators

  • Vienna Hospital Association

Investigators

  • Principal Investigator: Walter Bily, MD, Vienna HA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Walter Bily, MD, Representative Director, Vienna Hospital Association
ClinicalTrials.gov Identifier:
NCT04829955
Other Study ID Numbers:
  • Cardio eccentric protocol 3.5
First Posted:
Apr 2, 2021
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Walter Bily, MD, Representative Director, Vienna Hospital Association
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022